SCHEMBL20022403

SCHEMBL20022403

CCOC(=O)c1nc(-c2cccnc2)oc1C

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TARBP2 Q15633 7/20 0.70
PDCD4 Q53EL6 1/20 0.62
KDM4E B2RXH2 4/20 0.54
ALDH1A1 P00352 3/20 0.54
HPGD P15428 2/20 0.54
HSD17B10 Q99714 2/20 0.54
KMT2A Q03164 2/20 0.54
IKBKB O14920 1/20 0.52
CDC7 O00311 2/20 0.51
DBF4 Q9UBU7 2/20 0.51
MMP2 P08253 1/20 0.49
MMP13 P45452 1/20 0.49
MMP14 P50281 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
MAPT P10636 2/20 0.47
ALOX15 P16050 1/20 0.47
POLB P06746 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
DCTPP1 Q9H773 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18163567 0.86 TARBP2 (0.53) TARBP2PDCD4KDM4EALDH1A1HPGD
SCHEMBL2485336 0.85 TARBP2 (0.94) TARBP2PDCD4KDM4EALDH1A1HPGD
SCHEMBL28295536 0.84 TARBP2 (0.77) TARBP2PDCD4KDM4EALDH1A1HPGD
SCHEMBL28295518 0.83 TARBP2 (1.00) TARBP2PDCD4KDM4EALDH1A1HPGD
SCHEMBL20022402 0.82 IKBKB (0.58) TARBP2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL4918154 0.80 TARBP2 (1.00) TARBP2PDCD4KDM4EALDH1A1HPGD
SCHEMBL17768259 0.79 TARBP2 (0.82) TARBP2PDCD4KDM4EALDH1A1HPGD
SCHEMBL7907774 0.79 TARBP2 (0.82) TARBP2PDCD4KDM4EALDH1A1HPGD
SCHEMBL22436921 0.78 KDM4E (0.52) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL2112342 0.78 CA1 (0.57) KDM4EALDH1A1HPGDHSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180093968-A1 QUINOLINE DERIVATIVES AS TAM RTK INHIBITORS LEAD DISCOVERY CENTER GMBH (DE) 2018-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180093968-A1 QUINOLINE DERIVATIVES AS TAM RTK INHIBITORS TYRO3, MERTK, AXL TARBP2 3739/4885PDCD4 1289/4885KDM4E 1123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.